Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Acad Sci USA 122 , e2404899122 (2025)
A 2014 systematic review and meta-analysis of 31 randomized controlled trials in a total of 1,734 patients with ESRD found that L-carnitine treatment administered either orally or intravenously resulted in reductions of serum C-reactive protein (a marker of inflammation and predictor of mortality in patients undergoing hemodialysis) and LDL-cholesterol, although the latter was not deemed to be clinically relevant (73)
Gragnani, D
Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes
Horm Res Paediatr 78(1):5966
US$ 26.47
US$ 21.81
US$ 28.17
US$ 27.20
US$ 26.25
US$ 28.28
